NDA 013157

LILLY

FDA Drug Application

Application #013157

Application Sponsors

NDA 013157

LILLY

Marketing Status

• Discontinued: 002

Application Products

002

TABLET;ORAL

2MG

0

ANHYDRON

CYCLOTHIAZIDE

FDA Submissions

TYPE 1; Type 1 - New Molecular Entity	ORIG	1	AP	1963-08-20	STANDARD
LABELING; Labeling	SUPPL	7	AP	1977-03-18
LABELING; Labeling	SUPPL	10	AP	1985-11-01
LABELING; Labeling	SUPPL	11	AP	1989-09-21
LABELING; Labeling	SUPPL	12	AP	1990-11-08

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 13157
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)